TrialDiabetes, obesity & metabolism2015

Safety and efficacy of once-weekly dulaglutide versus sitagliptin after 2 years in metformin-treated patients with type 2 diabetes (AWARD-5): a randomized, phase III study.

R S Weinstock et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.